Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Path currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This single active matter is being reviewed by 1 distinct examiner. Prosecution for this portfolio is confined to 1 distinct art unit, reflecting a concentrated approach to their intellectual property development.
BARBER, KIMBERLY is the busiest examiner for Path, overseeing 1 pending office action. As there is only one pending action in the portfolio, this examiner manages the entire current workload. This distribution suggests that the company's current pharmaceutical interests are focused on a single technical path.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BARBER, KIMBERLY | 1 | 72.6% | +19.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18060766 | ENCAPSULATED PHARMACEUTICAL COMPOSITIONS, RELATED METHODS OF MAKING, AND RELATED METHODS OF TREATMENT | BARBER, KIMBERLY | — |
| Art Unit | Apps |
|---|---|
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18060766 | ENCAPSULATED PHARMACEUTICAL COMPOSITIONS, RELATED METHODS OF MAKING, AND RELATED METHODS OF TREATMENT | BARBER, KIMBERLY | 1615 | §103 | Final Rejection | — | Pending | Dec 01, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPath has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Kimberly Barber has the most, with 1 of Path's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
